Questions Surround Accuracy of Xarelto Clinical Trial

An Arkansas Xarelto injury lawyer notes that some doctors and health care professionals may be asking if certain peer-reviewed publications prioritize profits over accuracy when it comes to the clinical trial information they publish. Affected patients and their families may be eligible to file a lawsuit with the help of an Arkansas Xarelto attorney.

For more information, contact Attorney Group for Arkansas. We offer free, confidential, no obligation consultations. We can help answer your questions, and if you choose to pursue a case we can connect you with an affiliated Arkansas Xarelto Injury lawyer who can assist you throughout the legal process.

Important: The time you have to pursue a claim is limited. Contact us for more information.

Defective Device May Have Altered Xarelto Study Results

The controversy surrounding a clinical trial detailed in the New England Journal of Medicine (NEJM) is causing some industry insiders to question whether the publication publishes information selectively and in accordance with its own objectives. According to HealthNewsReview, allegations of industry-sponsored trials that reap tremendous financial benefits for publications is sparking concerns about whether this and other publications omit important data when doing so benefits them financially.

At the heart of the issue are the results produced by a clinical trial comparing the anticoagulants Xarelto and Coumadin, also known as warfarin. While the trial suggested Xarelto is a safer alternative to Coumadin, its results are under scrutiny because a blood-measurement device used in it has been shown to be defective. The device, since recalled by the U.S. Food and Drug Administration, may have resulted in some patients receiving inaccurate amounts of Coumadin, potentially slanting results in favor of Xarelto. The NEJM has since instituted a new rule stating that trial authors must produce their scientific data within six months of trial publication. Study sponsor Bayer refused to do so, however, citing the fact that this trial was published before the new rule took effect Jan. 1, 2014.

How an Arkansas Xarelto Injury Lawyer Can Help

Drug makers have a duty to provide safe products. If there are risks of harm associated with their products, they also must provide adequate warnings. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

People injured by bad drugs may be eligible to recover money for:

  • Medical Expenses
  • Lost Wages
  • Pain and Suffering

The families of those who have died may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.

The Time You Have to Pursue a Claim is Limited. Contact Us Today.

For more information, contact Attorney Group for Arkansas. You can fill out the form on this page or contact us by phone or email.

After you contact us, an attorney will follow up to answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.

Comments